Eledon Pharmaceuticals (ELDN) Total Liabilities (2013 - 2026)
Eledon Pharmaceuticals posted quarterly Total Liabilities of $46.2 million for Q1 2026, down 1.11% year-on-year from $46.7 million in Q1 2025, and up 43.37% on a QoQ basis from $32.2 million in Q4 2025.
Eledon Pharmaceuticals (ELDN) has 14 years of Total Liabilities data on file, last reported at $46.2 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities fell 1.11% year-over-year to $46.2 million; the trailing twelve-month figure through Mar 2026 stood at $46.2 million (down 1.11% YoY), and the FY2025 full-year result was $32.2 million, down 45.62% from the prior year.
- Total Liabilities for Q1 2026 stood at $46.2 million, up from $32.2 million in the prior quarter.
- Across five years, Total Liabilities topped out at $129.0 million in Q2 2024 and bottomed at $5.1 million in Q1 2022.
- The 5-year median for Total Liabilities is $38.9 million (2025), against an average of $45.0 million.
- The widest annual swing landed in 2024, when Total Liabilities soared 1171.57%; it then sank 69.86% in 2025.
- A 5-year view of Total Liabilities shows it stood at $8.6 million in 2022, then soared by 850.73% to $81.9 million in 2023, then decreased by 27.6% to $59.3 million in 2024, then tumbled by 45.62% to $32.2 million in 2025, then surged by 43.37% to $46.2 million in 2026.
- The last three Total Liabilities figures came in at $46.2 million (Q1 2026), $32.2 million (Q4 2025), and $38.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.74 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 731.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 177.22 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 19.51 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.12 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 10.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.45 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.05 Bn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | 46.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.21 Mn |
| Dec 31, 2025 | 32.23 Mn |
| Sep 30, 2025 | 38.80 Mn |
| Jun 30, 2025 | 38.88 Mn |
| Mar 31, 2025 | 46.73 Mn |
| Dec 31, 2024 | 59.27 Mn |
| Sep 30, 2024 | 38.52 Mn |
| Jun 30, 2024 | 128.98 Mn |
| Mar 31, 2024 | 95.55 Mn |
| Dec 31, 2023 | 81.86 Mn |
| Sep 30, 2023 | 60.47 Mn |
| Jun 30, 2023 | 63.02 Mn |
| Mar 31, 2023 | 7.51 Mn |
| Dec 31, 2022 | 8.61 Mn |
| Sep 30, 2022 | 8.49 Mn |
| Jun 30, 2022 | 5.33 Mn |
| Mar 31, 2022 | 5.06 Mn |
| Dec 31, 2021 | 6.55 Mn |
| Sep 30, 2021 | 6.42 Mn |
| Jun 30, 2021 | 5.78 Mn |
| Mar 31, 2021 | 7.81 Mn |
| Dec 31, 2020 | 6.59 Mn |
| Sep 30, 2020 | 6.13 Mn |
| Jun 30, 2020 | 1.15 Mn |
| Mar 31, 2020 | 1.98 Mn |
| Dec 31, 2019 | 1.47 Mn |
| Sep 30, 2019 | 1.85 Mn |
| Jun 30, 2019 | 2.18 Mn |
| Mar 31, 2019 | 3.52 Mn |
| Dec 31, 2018 | 2.53 Mn |
| Sep 30, 2018 | 1.60 Mn |
| Jun 30, 2018 | 1.45 Mn |
| Mar 31, 2018 | 1.62 Mn |
| Dec 31, 2017 | 1.44 Mn |
| Sep 30, 2017 | 2.40 Mn |
| Jun 30, 2017 | 3.41 Mn |
| Mar 31, 2017 | 2.47 Mn |
| Dec 31, 2016 | 3.90 Mn |
| Sep 30, 2016 | 6.46 Mn |
| Jun 30, 2016 | 7.97 Mn |
| Mar 31, 2016 | 6.30 Mn |
| Dec 31, 2015 | 6.25 Mn |
| Sep 30, 2015 | 5.71 Mn |
| Jun 30, 2015 | 4.66 Mn |
| Mar 31, 2015 | 5.75 Mn |
| Dec 31, 2014 | 4.24 Mn |
| Sep 30, 2014 | 5.37 Mn |
| Dec 31, 2013 | 2.21 Mn |